Details of the Drug Formulaction

General Information of Drug Formulation (ID: F18913)

• Formulation Name: Repaglinide 1 mg tablet
• Company: Gemini Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Repaglinide	(DM5SXUV)	Diabetic complication	5A2Y	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Carmellose sodium	(E00625)	Not Available	Disintegrant
Ferric hydroxide oxide yellow	(E00539)	23320441	Colorant
Magnesium stearate	(E00208)	11177	lubricant
Meglumine	(E00181)	8567	Buffering agent
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent